OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development17,406.86916,460.7148,777.519
Selling General and Administrative5,207.5156,946.0637,509.601
Non Recurring--338.906
Total Operating Expenses--17,805.28
Operating Income or Loss-23,780.073-24,596.053-17,805.28
Income from Continuing Operations
Total Other Income/Expenses Net-1.349-1,182.2482,716.535
Earnings Before Interest and Taxes-23,810.996-25,766.198-15,197.865
Interest Expense---
Income Before Tax-23,810.996-25,766.198-15,197.865
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-23,810.996-25,766.198-15,301.008
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-23,810.996-25,766.198-15,197.865
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-23,810.996-25,766.198-15,197.865